Careers
Do you want to help change thousands of lives?
Our core
We exist for our users, and we only have the right to exist if we create real value for our customers and users.
With us, you can truly make a difference
We are currently a small company with high ambitions at the beginning of our commercial journey. With roots from KTH and KI, we have a strong scientific foundation in everything we undertake, both medically and technically, and even today we collaborate with research teams to ensure that we always validate the utility of what we do.
Vacancies
We are a growing company that always wants to strengthen our team with the right competencies, even if there are no specific advertisements out.
We currently have no vacancies.
Evira has been used in clinical practice since 2018
Patients and clinical staff use Evira daily in the treatment of childhood obesity.
4500 +
Patients
Thousands of patients have received or are receiving help to treat their obesity with Evira today
1.5 years
in treatment average
This shows the median and mean for how long a patient is treated with Evira; it varies depending on the degree of obesity at the start of treatment, among other factors.
500 000+
Measurements
Half a million measurements have been carried out in the safety of the patients' own homes
−0,3
BMI-SDS
This is how much a patient's BMI-SDS (a measure of relative degree of overweight) decreases on average after one year of treatment with Evira.
7 000+
Years of treatment
Patients already contribute thousands of treatment years that we regularly analyse to improve the tool and treatment.
50
Clinics
This is how many clinics have used Evira for paediatric childhood obesity treatment in five different countries.
Evira is used here today
On the map, you can see which children's clinics use Evira to treat childhood obesity. Contact the Evira clinic nearest you if you want to know more about what it means to use Evira to treat your child's overweight.
Read more about Evira for families or get to know the team you will be working with.